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Sir,
Those who organize a Citizens' Jury have considerable power and responsibility. Not only are they required to select the witnesses but they have to brief the jury, organize the presentation of the information, moderate on the proceedings and report on the findings. It is thus important that organizers commissioned to arrange this democratic way of examining important questions enabling people to exercise their citizenship, recognize their accountability both to the sponsors and the public. They must be open and fair in all the aspects listed above. Consideration of selection of witnesses, both those who volunteer and those to be invited, must allow for as wide and balanced a spectrum of considerations as possible so that a representative cross-section of opinion is provided. This presentation of evidence then offers some chance of a fair verdict being decided by 12 (or more!) good men and true.
We are therefore pleased that our suggestion has resulted in the first volunteer. Our list of witnesses was not intended to be exhaustive, final or complete: only to stimulate consideration of this democratic method and elicit constructive suggestions.
H Thornton and M Baum
Prognostic value of cathepsin D in breast cancer Sir A recent publication in this journal demonstrated, that cathepsin D was an independent marker of poor prognosis in 2810 breast cancer patients (Foekens et al, 1999) . A covering editorial rose questions on the still unexplained biological role of cathepsin D in breast cancer (Westley et al, 1999) . Cathepsin D levels correlated with increasing invasiveness and high metastatic potential of tumour cells in breast cancer. Breast cancer cells were found to secrete cathepsin D into the cell culture medium. Thus, it is commonly hypothesized, that cathepsin D might be involved in the extracellular breakdown of the tumour stroma in vivo and contribute to tumour dissemination. This hypothesis needs comment and should be modified in view of recent findings. High cathepsin D levels are not only present in breast cancer samples, but have been described for a multitude of other tumour entities, such as laryngeal cancer, cancers of the head and neck, ovarian cancer, endometrial cancer, bladder cancer, or in malignant glioma. In these reports, high cathepsin D levels were usually also considered as a sign of a poor prognosis. High levels of other lysosomal cathepsins B, H and L have been detected in a variety of different cancers including breast cancer, as well (Recklies et al, 1980) . These observations clearly indicate that a highly active lysosomal system is characteristic of cancer tissue.
Lysosomes are involved in the degradation of extracellular material ingested by endocytosis. Cathepsins are intralysosomally active at pH 3-5 and loose most activity at a neutral pH (Bohley et al, 1992) . Although cathepsin D might be secreted by cancer cells, there is no evidence available that the secreted enzyme is actively involved in the extracellular degradation of the extracellular matrix (ECM) at the neutral or slightly acidic pH in tumour tissues in vivo. In cell culture, extracellular degradation of ECM mediated by cathepsin D was only achieved after lowering the pH to 4.5 in the cell culture media, but not at pH 7.4 (Briozzo et al, 1988) . When invasiveness of breast cancer cells was studied in the Boyden chamber, the secretion of cathepsin D even correlated inversely with the aggressive behaviour of the cancer cells (Johnson et al, 1993) . To our knowledge extracellular acidic compartments containing proteases of lysosomal origin involved in a break-down of ECM, have not been found in tumour tissues.
In contrast, there are a variety of other formidable proteases available, which are responsible for extracellular proteolysis of the ECM (recently reviewed by Price et al, 1997) . All of these are active at a neutral pH, and highly regulated by their respective inhibitors. These proteases belong to the plasminogen activator (PA) or to the matrix metalloproteinase (MMP) superfamilies. Increased expression of PA and MMPs in a variety of tumours, including breast cancer, are associated with a high metastatic potential and poor prognosis (Stetler Stevenson et al, 1996; Duffy et al, 1998) . Invasive cells form specialized membrane protrusions, called invadopodia, that actively degrade the surrounding ECM (Kelly et al, 1994) . MMPs are structurally and functionally linked with invadopodia (Chen, 1996; Nakahara et al, 1997) . To our knowledge there are no reports on cathepsin activity in connection to invadopodia so far.
Instead, considerable evidence points to an important role for cathepsins as proteolytic enzymes in the lysosomal system. Invasive breast cancer cells were able to ingest considerable amounts of extracellular material in large acid phagosomes (pH < 4). The presence of these phagosomes coincided with an increased ability of these cells to migrate through matrigel, and with high cathepsin D levels (Montcourrier et al, 1990 (Montcourrier et al, , 1994 . Recent data support these observations, indicating that MMPs were responsible for the partial degradation of a cross-linked gelatine matrix. The gelatin fragments were taken up by phagocytosis and destined to lysosomes for further degradation. This phagocytic capacity of breast cancer cells was directly linked to their invasiveness (Coopman et al, 1998) .
Further observations strengthen the concept of an active lysosomal digestive system and hence high cathepsin D levels in malignant tumours. Tumours have been termed nitrogen traps. During tumour cell proliferation extensive amounts of nitrogenous substrates are required to provide material for cell duplication (new tumour proteins, DNA, RNA …). Free amino acid concentrations in blood are low, leaving only plasma proteins (mostly albumin) as the major external source for additional nitrogen, necessary during tumour proliferation . And indeed, there are reports confirming albumin accumulation and degradation in tumours (Sinn et al, 1990; Andersson et al, 1991; Wunder et al, 1997) . In sarcoma-bearing mice the intralysosomal accumulation of residualizingly radiolabelled albumin was threefold higher in tumour tissue compared to liver tissue. Accounting for the entire tumour the proteolytic capacity for albumin breakdown exceeded that of the healthy liver by a factor of five (Andersson et al, 1991) . Interestingly, cathepsin D is closely involved in the lysosomal catabolism of albumin (Mego, 1984) . A considerably increased intracellular albumin content was found in an immunohistological study of breast cancer tissue (Vercelli Retta et al, 1987) . High plasma protein (albumin) accumulation was also detected in homogenized tumour tissue from mastectomy specimens. A significant correlation between high plasma protein content in the samples and poor prognosis in breast cancer patients was established (Soreide et al, 1991a (Soreide et al, , 1991b .
ECM fragments and plasma proteins have been identified as substrates for lysosomal cathepsins. Tumour cell apoptosis might provide further material doomed for lysosomal digestion. Tumours have a high rate of cell turnover, and e.g. the cell loss was established as high as 96% (Refsum et al, 1967) . Remnants of apoptotic cells might be recognized and rapidly phagocytosed by neighbouring cells in the tissue (Collins et al, 1993) . A high apoptotic index in breast cancer cells was associated with a high mitotic rate, tumour necrosis, dense stromal lymphocyte infiltration, lack of tubule formation, lack of sex steroid receptor expression, a high grade tumour and with a short recurrence free survival (Lipponen et al, 1994) . In addition, macrophages might also be involved in the phagocytosis of apoptotic cells (Savill et al, 1993) . The role of macrophages, leucocytes, fibroblasts or of neighbouring tumour cells in the clearance and degradation of apoptotic cell remnants still remain to be further clarified. Interestingly, high cathepsin D levels also coincide with all of these cell types present in breast cancer tissue.
Based on these observations, we conclude that the biological role of cathepsin D is mostly confined to the lysosomal system. High cathepsin D levels in tumour tissues reflect high lysosomal turnover. This turnover is likely to be caused by an increased uptake and digestion of ECM fragments, of plasma proteins, and of cellular debris (remnants of apoptotic cells?) mostly by proliferating cancer cells. The ingested and degraded materials might serve as tumour cell nutrients. A positive correlation of cathepsin D with tumour malignancy or metastatic potential is obvious. It is evident, that further research is needed to investigate the role of the lysosomal system during tumour cell proliferation.
